Best in Biotech 4 Nov 2022
Get to know 15 of the best biotech companies in Paris
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In this guide, we explore 15…
GenSight Biologics
- Latest Posts
In Depth 10 Mar 2021
Can Gene Therapy Cure Blindness?
Since the approval of the first gene therapy for blindness, there has been a wave of companies developing gene therapy…
More News! 17 Oct 2019
Sofinnova Partners Raises €333M for its Newest Life Sciences-Focused Fund
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage healthcare companies, bringing the total…
News and Trends 29 May 2019
After Unexpected Setback, GenSight Seeks Approval for Blindness Gene Therapy
The French biotech GenSight will apply for regulatory approval for its gene therapy despite the treatment unexpectedly resulting in the…
ADVERTISEMENT
News and Trends 4 Apr 2018
Placebo Beats a Gene Therapy for Blindness in a Phase 3 Trial
GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly improve the vision of patients.…
News and Trends 20 Feb 2018
This Gene Therapy for Vision Loss is Safe and Effective After Two Years
The results of a long-term follow-up suggest that GenSight's gene therapy for Leber hereditary optic neuropathy can provide safe and…
News and Trends 10 Jan 2018
French Biotech Starts Trials to Restore Sight in All Types of Retinitis Pigmentosa
GenSight will start a clinical trial in the UK testing a combination of gene therapy and a wearable device to…
Best in Biotech 9 Jan 2018
Happy 2018, Here Are the Top 9 European Biotech Companies To Watch
As the 2017 reports roll in, we're already turning our gaze to 2018. These are the top European biotech companies…
Best in Biotech 18 Dec 2017
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread some Christmas cheer with the…
News and Trends 5 Dec 2017
Update: French Gene Therapy Yields Longer Term Sight Restoration, Eyes Phase III
Update (05/12/2017): GenSight has reported a sustained effect of its treatment GS010, which has now been shown to restore sight…
In Depth 28 Nov 2017
Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix each of them. Here's a…
More News! 23 Jun 2017
French Biotech Raises Over €22M to Launch a Gene Therapy to Restore Sight
Gensight Biologics has announced a capital increase that totals €22.5M and will support the launch of its gene therapy for…
News and Trends 26 Dec 2016
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash…
News and Trends 14 Nov 2016
Meet one of the Most Impressive French Biotech Entrepreneurs
The previous executive profiles we did, namely on Joern Aldag and Philippe Dro, are hard acts to follow, but Bernard Gilly…
News and Trends 21 Jul 2016
UPDATED: French Gene Therapy for Blindness Launches another IPO
Update (21/07/2016): Gensight has successfully completed its IPO, raising €40M. This brings the Biotech's total market capitalization to near €149M. The…
News and Trends 18 Apr 2016
ITW: This Biotech Startup wants to fix Youth Blindness with a Gene Therapy
While on a stop in New York, I had a chance to chat with Bernard Gilly, the founder and CEO…
ADVERTISEMENT
News and Trends 23 Jan 2015
A glimpse of the future: the revolution of bionic eyes
Six months after the surgery, the first Spanish with a bionic eye has gone from the total darkness to discern…
